Rasa vs Anthropic
Side-by-side comparison of AI visibility scores, market position, and capabilities
Open generative conversational AI platform for enterprise-grade AI agents across voice and chat. $83.8M raised (Series C Feb 2024, a16z/PayPal Ventures); multimodal voice AI launched Jun 2025.
About
Rasa is an enterprise-focused open-source and commercial platform for building, deploying, and managing conversational AI agents. Founded in 2016 and based in San Francisco, Rasa enables developers and enterprises to create AI assistants that run on private infrastructure with any large language model — addressing data privacy, security, and compliance requirements that preclude use of third-party SaaS chatbots. The platform supports voice and chat channels and is trusted by Fortune 500 companies in banking, healthcare, telecom, and retail. Rasa raised $30M in a Series C round in February 2024, co-led by StepStone Group and PayPal Ventures with participation from Andreessen Horowitz and Accel, bringing total funding to $83.8M. In June 2025, Rasa launched multimodal voice AI for enterprises and published its 2026 State of Conversational AI Report.
Claude 4 family (claude-opus-4-6, claude-sonnet-4-6, claude-haiku-4-5) at $5B ARR (2025); $183B valuation (Series F, Sept 2025); $14.3B raised — Amazon $8B, Google $2B; Claude Code at $500M+ ARR; 300K+ business customers; Claude.ai 18M+ MAU;
About
Anthropic is a San Francisco-based AI safety and research company that builds the Claude family of large language models. As of 2026, the current Claude 4 generation includes claude-opus-4-6 (most capable, reasoning and agentic tasks), claude-sonnet-4-6 (balanced performance and speed), and claude-haiku-4-5 (fast and cost-efficient). Anthropic also offers Claude Code — an agentic CLI for software engineering — generating $500M+ ARR by mid-2025.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.